920 resultados para Metabolismo do ferro


Relevância:

10.00% 10.00%

Publicador:

Resumo:

Tese de dout., Ciências Agrárias, Unidade de Ciências e Tecnologias Agrárias (Produção Vegetal), Univ. do Algarve, 2000

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Tese de dout., Ciências Biotecnológicas (Biotecnologia Vegetal), Univ. do Algarve, 2009

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Dissertação de mest., Engenharia Biológica, Faculdade de Ciências e Tecnologia, Univ. do Algarve, 2011

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Dissertação de mest., Biologia Molecular e Microbiana, Faculdade de Ciências e Tecnologia, Univ. do Algarve, 2011

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Tese mest., Biologia Marinha, Universidade do Algarve, Faculdade de Ciências do Mar e do Ambiente, 2008

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Dissertação de mest., Hortofruticultura, Faculdade de Ciências e Tecnologia, Univ. do Algarve, 2013

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Dissertação de mest., Tecnologia dos Alimentos , Instituto Superior de Engenharia, Univ. do Algarve, 2013

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Dissertação de mest., Qualidade em Análises, Faculdade de Ciências e Tecnologia, Univ. do Algarve, 2013

Relevância:

10.00% 10.00%

Publicador:

Resumo:

As reacções adversas a medicamentos (RAM) encontram-se entre uma das principais causas de morbilidade e mortalidade em muitos países. [1, 2] Assim sendo, torna-se necessário promover uma utilização segura e efectiva dos medicamentos de forma a garantir a segurança do doente. Neste contexto surge a farmacovigilância, a qual se encontra definida pela Organização Mundial de Saúde (OMS) como “a ciência e actividades relacionadas com a detecção, avaliação, compreensão e prevenção dos efeitos adversos ou de quaisquer outros problemas relacionados com os medicamentos”. [3] A farmacovigilância hospitalar constitui um instrumento importante uma vez que neste ambiente é mais provável a ocorrência de RAM graves e de RAM novas e inesperadas, devido à utilização de terapêuticas inovadoras e potencialmente agressivas. [4] Além disso, a posição privilegiada do farmacêutico hospitalar no acompanhamento farmacoterapêutico dos doentes agudos e de grupos de risco (idosos, grávidas e crianças) pode auxiliar na prevenção e detecção de algumas RAM. O objectivo geral desta monografia é caracterizar a farmacovigilância, especialmente em ambiente hospitalar e na perspectiva do farmacêutico

Relevância:

10.00% 10.00%

Publicador:

Resumo:

O Citocromo P450 2D6 (CYP 2D6) é uma importante enzima metabolizadora de fármacos. Apesar de representar apenas 2% do total das isoenzimas CYP, o CYP 2D6 tem um papel importante pois é responsável pela metabolização de cerca de 20 a 25% dos fármacos mais frequentemente utilizados. (Ramamoorthy, 2010) É sabido que nem todos os indivíduos respondem da mesma maneira a um fármaco, podendo alguns sofrer reação adversa devido à toma deste e outros nem apresentar qualquer efeito terapêutico. Tais diferenças na resposta terapêutica devem-se a variações genómicas interindividuais, nos genes que codificam as enzimas responsáveis pelo metabolismo do fármaco. Os alelos polimórficos podem levar a uma redução ou aumento na capacidade metabólica, ao passo que um aumento do número de cópias do gene CYP 2D6 pode conduzir a um aumento da atividade metabólica. Os indivíduos comportam-se de acordo com o seu fenótipo, como metabolizadores lentos, rápidos ou ultra-rápidos (Abraham, 2001) Visto existirem grandes alterações nesta enzima metabolizadora de fármacos, é importante perceber quais as situações onde a segurança e a eficácia estão alteradas, pois qualquer terapêutica tem sempre como base o binómio risco/beneficio. Para além do seu papel bem estabelecido na segurança e eficácia terapêutica, estudos mais recentes relatam que o CYP 2D6 desempenha um papel importante no aparecimento de algumas doenças, condicionando a predisposição individual para patologias, de que é exemplo a esclerose sistémica. (Sanjay Harhang & al, 2001) Como desenvolvimento desta monografia pretende-se estudar os efeitos a nível de segurança e eficácia em determinadas situações terapêuticas e ainda avaliar a associação dos polimorfismos no CYP 2D6 com a predisposição individual para patologias.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

The aquaculture industry aims at replacing significant amounts of marine fish oil by vegetable oils in fish diet. Dietary lipids have been shown to alter the fatty acid composition of bone compartments, which would impact the local production of factors controlling bone formation. Knowledge on the mechanisms underlying the nutritional regulation of bone metabolism is however scarce in fish. Two in vitro bone-derived cell systems developed from seabream (an important species for aquaculture in the Mediterranean region) vertebra, capable of in vitro mineralization and exhibiting prechondrocyte (VSa13) and pre-osteoblast (VSa16) phenotype, were used to assess the effect of certain polyunsaturated fatty acids (PUFAs; arachidonic (AA), eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids) on cell proliferation, extracellular matrix (ECM) mineralization and gene expression. While all PUFAs promoted morphological changes in both cell lines, VSa16 cell proliferation appeared to be stimulated by PUFAs in a dose dependent manner until 100M, whereas proliferation of VSa13 cells was impaired at concentrations above 10M. AA, EPA and DHA inhibited VSa13 ECM mineralization, alone and in combination, while VSa16 ECM mineralization was only inhibited by AA and EPA. DHA had the opposite effect, increasing mineralization almost by 2 fold. When EFAs were combined, DHA apparently compensated for the inhibitory effect of AA and EPA. Expression of marker genes for bone and lipid metabolisms has been investigated by qPCR and shown to be regulated in pre-osteoblasts exposed to individual PUFAs. Our results show that PUFAs are effectors of fish bone cell lines, altering cell morphology, proliferation and mineralization when added to culture medium. This work also demonstrates the suitability of our in vitro cell systems to get insights into mineralization-related effects of PUFAs in vivo and to evaluate the replacement of fish oils by vegetable oil sources in fish feeds.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

It is widely recognized that protein restriction in utero may cause metabolic and endocrine adaptations, which may be of benefit to the neonate on a short-term basis but may cause adverse long-term conditions such as obesity, Type 2 diabetes, metabolic syndrome, hypertension and cardiovascular diseases. Adequate foetal and early post natal nutrient and energy supply is therefore essential for adult animal health, performance and life span. In this project it was investigated the progressive adaptations of the hepatic proteome in male mink offspring exposed to either a low protein (FL) or an adequate protein (FA) diet in utero fed either on a low protein (LP) or on an adequate (AP) diet from weaning until sexual maturity. Specifically, the aim was to determine the metabolic adaptations at selected phases of the animal’s first annual cycle and establish the metabolic priorities occurring during those phases. The three different morphological stages studied during the first year of development included, end of bone growth at 4 months of age, maximal fat accretion at 6 months of age and sexual maturity at 12 months of age. A reference proteome of mink liver coming from these different animal groups were generated using 2D electrophoresis coupled to MALDI-TOF analysis and the way in which dietary treatment affect their proteome was established. Approximately 330 proteins were detected in the mink liver proteome. A total of 27 comparisons were carried out between all different animal groups which resulted in 20 differentially expressed proteins. An extensive survey was conducted towards the characterization of these proteins including their subcellular localization, the biological processes in which they are involved and their molecular functions. This characterization allowed the identification of proteins in various processes including the glycolysis and fatty acid metabolism. The detailed analysis of the different dietary treatment animal groups was indicative of differences in metabolism and also to changes associated with development in mink.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Infectious diseases often hamper the production of aquatic organisms in aquaculture systems, causing economical losses, environmental problems and consumer safety issues. The conventional way aquaculture producers had to control pathogens was by means of synthetic antibiotics and chemicals. This procedure had consequences in the emergence of more resilient pathogens, drug contamination of seafood products and local ecosystems. To avoid the repercussions of antibiotic use, vaccination has greatly replaced human drugs in western fish farms. However there is still massive unregulated antibiotic use in third world fish farms, so less expensive therapeutic alternatives for drugs are desperately needed. An alternative way to achieve disease control in aquaculture is by using natural bioactive organic compounds with antibiotic, antioxidant and/or immunostimulant properties. Such diverse biomolecules occur in bacteria, algae, fungi, higher plants and other organisms. Fatty acids, nucleotides, monosaccharides, polysaccharides, peptides, polyphenols and terpenoids, are examples of these substances. One promising source of bioactive compounds are salt tolerant plants. Halophytes have more molecular resources and defence mechanisms, when compared with other tracheophytes, to deal with the oxidative stresses of their habitat. Many halophytes have been used as a traditional food and medical supply, especially by African and Asian cultures. This scientific work evaluated the antibiotic, antioxidant, immunostimulant and metal chelating properties of Atriplex halimus L., Arthrocnemum macrostachyum Moric., Carpobrotus edulis L., Juncus acutus L. and Plantago coronopus L., from the Algarve coast. The antibiotic properties were tested against Listonella anguillarum, Photobacterium damselae piscicida and Vibrio fischeri. The immunostimulant properties were tested with cytochrome c and Griess assays on Sparus aurata head-kidney phagocytes. J. acutus ether extract inhibited the growth of P. damselae piscicida. A. macrostachyum, A. halimus, C. edulis, Juncus acutus and P. coronopus displayed antioxidant, copper chelating and iron chelating properties. These plants show potential as sources of bioactive compounds with application in aquaculture and in other fields.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Cytochromes P450 constitute a super-family of enzymes involved in the metabolism of Xenobiotics, where human cytochrome P450 3A4 is the most abundant of all P450s, accounting for about 50% of all human liver cytochromes. This membrane anchored protein is responsible for the metabolization of a wide array of environmental drugs and intoxicants, mainly due to its haem domain properties, and active site cavity volume. These properties make this protein an excellent subject for biosensor application, although CYO3A4 enzyme is also famous for its instability. Enzyme inactivation at room temperature is a normal conversion process that this enzyme undergoes, that may hamper any biosensing approach.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

The human genome has millions of genetics variants that can affect gene expression. These variants are known as cis-regulatory variants and are responsible for intra-species phenotypic differences and individual susceptibility to disease. One of the diseases affected by cis-regulatory variants is breast cancer. Breast cancer is one of the most common cancers, with approximately 4500 new cases each year in Portugal. Breast cancer has many genes mutated and TP53 has been shown to be relevant for this disease. TP53 is one of the most commonly mutated genes in human cancer and it is involved in cell cycle regulation and apoptosis. Previous work by Maia et al has shown that TP53 has differential allelic expression (DAE), which suggests that this gene may be under the influence of cis-regulatory variants. Also, its DAE pattern is totally altered in breast tumours with normal copy number. We hypothesized that cis-regulatory variants affecting TP53 may have a role in breast cancer development and treatment. The present work aims to identify the cis-regulatory variants playing a role in TP53 expression, using in silico, in vitro and in vivo approaches. By bioinformatic tools we have identified candidate cis-regulatory variants and predicted the possible transcription factor binding sites that they affect. By EMSA we studied DNA-protein interactions in this region of TP53. The in silico analysis allowed us to identified three candidate cis-regulatory SNPs which may affect the binding of seven transcription factors. However, the EMSA experiments have not been conclusive and we have not yet confirmed whether any of the identified SNPs are associated with gene expression control of TP53. We will carry out further experiments to validate our findings.